ProFrac Holding ACDC 深 沪
等待开盘 05-19 09:30:00 美东时间
7.81
+0.530
+7.28%
华盛通- 最 高7.925
- 今 开7.47
- 成交量 173.18万股
- 最 低 7.355
- 昨 收 7.28
- 总市值 14.13亿
- 52周最高 10.70
- 市盈率 静 --
- 换手率 0.96%
- 52周最低 3.08
- 委 比 56.53%
- 总股本 1.81亿
- 历史最高 27.00
- 量 比 1.61
- 振 幅 7.83%
- 历史最低 3.08
- 每 手 1
- 风险率 1.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
今天 10:55
Piper Sandler Maintains Neutral on ProFrac Holding, Raises Price Target to $6
Piper Sandler analyst Derek Podhaizer maintains ProFrac Holding (NASDAQ:ACDC) with a Neutral and raises the price target from $5 to $6.
05-18 22:30
ProFrac Holding shares are trading lower after the company reported worse-than-expected Q1 sales results.
ProFrac Holding shares are trading lower after the company reported worse-than-...
05-08 00:38
ProFrac Holding Q1 Sales $449.600M Miss $450.135M Estimate
ProFrac Holding (NASDAQ:ACDC) reported quarterly sales of $449.600 million which missed the analyst consensus estimate of $450.135 million by 0.12 percent. This is a 25.10 percent decrease over sales of $600.300 million
05-07 17:53
ProFrac Q1 revenue rises sequentially, net loss narrows
ProFrac Q1 revenue rises sequentially, net loss narrows Overview U.S. energy services firm's Q1 revenue rose sequentially but fell short of year-ago levels Company posted Q1 net loss of $81 mln, narrower than prior quarter's loss Q1 results impacted by weather disruptions; operator activity improved
05-07 17:24
美股大行评级 | 大行互评！花旗银行、贝莱德获多家大行上调目标价；哈里伯顿、强生、Patterson获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Knightscope"买入"评级，目标价从25美元升至26美元；杰富瑞：维持Allogene疗法"买入"评级，目标价从6美元升至10美元
04-16 10:14
Morgan Stanley Maintains Underweight on ProFrac Holding, Raises Price Target to $6
Morgan Stanley analyst Daniel Kutz maintains ProFrac Holding (NASDAQ:ACDC) with a Underweight and raises the price target from $5 to $6.
04-16 01:59
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
Morgan Stanley Maintains Underweight on ProFrac Holding, Raises Price Target to $5
Morgan Stanley analyst Daniel Kutz maintains ProFrac Holding (NASDAQ:ACDC) with a Underweight and raises the price target from $4 to $5.
03-24 22:02
Analysts Offer Insights on Energy Companies: APA (APA) and ProFrac Holding (ACDC)
Companies in the Energy sector have received a lot of coverage today as analyst...
03-24 18:50
